Venous function after pharmacomechanical thrombolysis for extensive iliofemoral deep vein thrombosis

SA Journal of Radiology

 
 
Field Value
 
Title Venous function after pharmacomechanical thrombolysis for extensive iliofemoral deep vein thrombosis
 
Creator Greeff, Wim Dehghan-Dehnavi, Ali Reza van Marle, Jacobus
 
Subject Radiology; Interventional Radiology venous function; pharmacomechanical thrombolysis; proximal deep venous thrombosis; quality of life
Description Background: Chronic venous insufficiency is an important complication following iliofemoral deep venous thrombosis. Early thrombus removal may preserve venous function and prevent this complication. This study represents the largest reported South African series of pharmacomechanical thrombolysis for iliofemoral deep venous thrombosis to date.Objective: To evaluate the long-term outcome following pharmacomechanical thrombolysis for proximal and extensive deep venous thrombosis in a private, specialist vascular unit.Methods: All patients who underwent pharmacomechanical thrombolysis for iliofemoral deep venous thrombosis between August 2009 and January 2016 were invited to return for clinical assessment and venous ultrasound. Clinical findings were recorded according to the Villalta score and clinical, etiology, anatomic and pathology (CEAP) classification. The quality of life (QoL) was assessed utilising the VEINES-QoL/Sym questionnaire, providing two scores per patient, one describing the QoL and the other symptom severity (Sym).Results: Thirty two patients (35 legs) were evaluated. There were 25 females and 7 males, with a mean age of 33.5 years (±14 years). The mean follow-up period was 31 months (range 3 months – 80 months). Results of the CEAP classification were C0 = 24 (75%), C1 = 1 (4%), C2 = 2 (6%), C3 = 2 (6%) and C4 = 3 (9%). Thirty-one (97%) patients had Villalta scores from 0 to 4, indicating no or mild evidence of venous disease. One patient (3%) had a Villalta score of 6, indicating post-thrombotic syndrome. The mean QoL score was 87% (±12) and the mean Sym score was 86% (±14). Twenty-four (75%) patients had no abnormality on ultrasound, with fibrosis the most observed abnormality.Conclusion: Most patients who had undergone pharmacomechanical thrombolysis for extensive iliofemoral deep venous thrombosis showed few significant clinical signs of chronic venous insufficiency, had excellent function on venous ultrasound and reported excellent QoL.
 
Publisher AOSIS
 
Contributor
Date 2017-08-29
 
Type info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion — —
Format text/html application/epub+zip text/xml application/pdf
Identifier 10.4102/sajr.v21i1.1214
 
Source South African Journal of Radiology; Vol 21, No 1 (2017); 5 pages 2078-6778 1027-202X
 
Language eng
 
Relation
The following web links (URLs) may trigger a file download or direct you to an alternative webpage to gain access to a publication file format of the published article:

https://sajr.org.za/index.php/sajr/article/view/1214/1564 https://sajr.org.za/index.php/sajr/article/view/1214/1563 https://sajr.org.za/index.php/sajr/article/view/1214/1565 https://sajr.org.za/index.php/sajr/article/view/1214/1561
 
Coverage South Africa August 2009-January 2016 —
Rights Copyright (c) 2017 Wim Greeff, Ali Reza Dehghan-Dehnavi, Jacobus van Marle https://creativecommons.org/licenses/by/4.0
ADVERTISEMENT